Becton Dickinson (BDX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $193.76, +2.58% vs the prior close of $188.89.
- Volume 1.97M shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BDX rises 2.6% to $193.76, a 52-week high. Closed at $193.76, +2.58% vs the prior close of $188.89. Day range $189.51–$194.34, opened at $192.00.
BDX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BDX rises 2.6% to $193.76, a 52-week high
- Closed at $193.76, +2.58% vs the prior close of $188.89. Day range $189.51–$194.34, opened at $192.00.
- Volume was 1.97M shares, 1.1x its 50-day average of 1.77M.
- Price is +5.5% vs its 50-day average ($183.58) and +18.2% vs its 200-day average ($163.91).
- 52-week range $127.59–$194.34; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 14, 2026 — BDX rises 0.8% to $188.89
- Closed at $188.89, +0.81% vs the prior close of $187.37. Day range $186.04–$189.68, opened at $188.26.
- Volume was 1.65M shares, 0.9x its 50-day average of 1.78M.
- Price is +3.2% vs its 50-day average ($183.12) and +15.4% vs its 200-day average ($163.71).
- 52-week range $127.59–$193.07; today's close sits at 94% of that range, 2.2% below the 52-week high.
Oct 13, 2026 — BDX dips 0.8% to $187.37
- Closed at $187.37, -0.80% vs the prior close of $188.89. Day range $185.59–$189.99, opened at $189.82.
- Volume was 1.15M shares, 0.6x its 50-day average of 1.79M.
- Price is +2.5% vs its 50-day average ($182.75) and +14.6% vs its 200-day average ($163.53).
- 52-week range $127.59–$193.07; today's close sits at 91% of that range, 3.0% below the 52-week high.
Oct 12, 2026 — BDX rises 2.8% to $188.89, a 1-month high, 3 up days in a row
- Closed at $188.89, +2.80% vs the prior close of $183.75. Day range $184.32–$188.92, opened at $184.32.
- Volume was 1.18M shares, 0.7x its 50-day average of 1.81M.
- Price is +3.6% vs its 50-day average ($182.40) and +15.6% vs its 200-day average ($163.37).
- 52-week range $127.59–$193.07; today's close sits at 94% of that range, 2.2% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — BDX rises 0.5% to $183.75
- Closed at $183.75, +0.55% vs the prior close of $182.75. Day range $181.51–$183.85, opened at $181.89.
- Volume was 1.62M shares, 0.9x its 50-day average of 1.82M.
- Price is +1.0% vs its 50-day average ($181.94) and +12.6% vs its 200-day average ($163.19).
- 52-week range $127.59–$193.07; today's close sits at 86% of that range, 4.8% below the 52-week high.
Oct 8, 2026 — BDX rises 1.4% to $182.75
- Closed at $182.75, +1.44% vs the prior close of $180.16. Day range $178.90–$182.76, opened at $179.76.
- Volume was 1.52M shares, 0.8x its 50-day average of 1.83M.
- Price is +0.6% vs its 50-day average ($181.57) and +12.1% vs its 200-day average ($163.05).
- 52-week range $127.59–$193.07; today's close sits at 84% of that range, 5.3% below the 52-week high.
Oct 7, 2026 — BDX ends flat (-0.1%) to $180.16
- Closed at $180.16, -0.08% vs the prior close of $180.30. Day range $177.92–$182.38, opened at $180.34.
- Volume was 1.92M shares, 1.0x its 50-day average of 1.84M.
- Price is -0.6% vs its 50-day average ($181.28) and +10.6% vs its 200-day average ($162.90).
- 52-week range $127.59–$193.07; today's close sits at 80% of that range, 6.7% below the 52-week high.
Oct 6, 2026 — BDX ends flat (-0.2%) to $180.30
- Closed at $180.30, -0.20% vs the prior close of $180.67. Day range $180.12–$187.45, opened at $183.35.
- Volume was 2.05M shares, 1.1x its 50-day average of 1.83M.
- Price is -0.4% vs its 50-day average ($181.01) and +10.8% vs its 200-day average ($162.77).
- 52-week range $127.59–$193.07; today's close sits at 80% of that range, 6.6% below the 52-week high.
Oct 5, 2026 — BDX rises 2.2% to $180.67
- Closed at $180.67, +2.19% vs the prior close of $176.80. Day range $176.04–$180.90, opened at $176.58.
- Volume was 1.65M shares, 0.9x its 50-day average of 1.82M.
- Price is +0.0% vs its 50-day average ($180.58) and +11.1% vs its 200-day average ($162.63).
- 52-week range $127.59–$193.07; today's close sits at 81% of that range, 6.4% below the 52-week high.
Oct 2, 2026 — BDX dips 0.7% to $176.80, 4 down days in a row
- Closed at $176.80, -0.71% vs the prior close of $178.07. Day range $175.71–$178.13, opened at $177.46.
- Volume was 1.87M shares, 1.0x its 50-day average of 1.81M.
- Price is -1.8% vs its 50-day average ($180.09) and +8.8% vs its 200-day average ($162.50).
- 52-week range $127.59–$193.07; today's close sits at 75% of that range, 8.4% below the 52-week high.
- That makes 4 straight losses.
BDX latest news & SEC filings
Every SEC filing by or about BDX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Feld Michael sold 76 shares at $183.70 (≈$13.96K) on Sep 28, 2026; now holds 19,644
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Feld Michael sold 165 shares at $188.49 (≈$31.10K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $4.98B (prior year $4.73B) (+5.4% vs Jun 30, 2025)
- Net income: $377.00M (prior year $574.00M) (-34.3% vs Jun 30, 2025)
- Diluted EPS: $1.37 (prior year $2.00) (-31.5% vs Jun 30, 2025)
Aug 6, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 22, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 29, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Jun 29, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade BDX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Apr 2, 2026, Feb 9, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.08% (largest 2.8%).
- Liquidity: about 1.82M shares (≈$351.88M) trade per day on average.
- 52-week position: $193.76 vs a range of $127.59–$194.34 (99% of the range).
- Dividends: last ex-dividend date Sep 9, 2026 ($1.05/share); 4 payments in the past 12 months.
- Splits: 1272:1000 on Feb 10, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 22 sales; latest: Michael Feld sold 76 shares on Sep 28, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jul 22, 2026.
- Share count: 272.39M shares outstanding (Jun 30, 2026), -5.0% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
BDX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 192.00 | 194.34 | 189.51 | 193.76 | 1.97M |
| Oct 14, 2026 | 188.26 | 189.68 | 186.04 | 188.89 | 1.65M |
| Oct 13, 2026 | 189.82 | 189.99 | 185.59 | 187.37 | 1.15M |
| Oct 12, 2026 | 184.32 | 188.92 | 184.32 | 188.89 | 1.18M |
| Oct 9, 2026 | 181.89 | 183.85 | 181.51 | 183.75 | 1.62M |
| Oct 8, 2026 | 179.76 | 182.76 | 178.90 | 182.75 | 1.52M |
| Oct 7, 2026 | 180.34 | 182.38 | 177.92 | 180.16 | 1.92M |
| Oct 6, 2026 | 183.35 | 187.45 | 180.12 | 180.30 | 2.05M |
| Oct 5, 2026 | 176.58 | 180.90 | 176.04 | 180.67 | 1.65M |
| Oct 2, 2026 | 177.46 | 178.13 | 175.71 | 176.80 | 1.87M |
| Oct 1, 2026 | 179.11 | 179.67 | 177.02 | 178.07 | 1.29M |
| Sep 30, 2026 | 181.19 | 182.34 | 178.91 | 179.00 | 1.80M |
| Sep 29, 2026 | 182.51 | 182.95 | 180.09 | 181.97 | 1.53M |
| Sep 28, 2026 | 183.07 | 184.34 | 181.95 | 183.83 | 1.88M |
| Sep 25, 2026 | 179.22 | 183.92 | 177.87 | 183.82 | 1.47M |
| Sep 24, 2026 | 182.73 | 183.72 | 178.98 | 179.23 | 1.40M |
| Sep 23, 2026 | 182.10 | 184.37 | 181.31 | 182.52 | 1.02M |
| Sep 22, 2026 | 182.40 | 183.83 | 180.75 | 183.00 | 1.46M |
| Sep 21, 2026 | 181.25 | 181.53 | 179.98 | 180.70 | 1.46M |
| Sep 18, 2026 | 179.76 | 182.62 | 179.42 | 180.94 | 6.41M |
About Becton Dickinson
Becton Dickinson (BDX) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in FRANKLIN LAKES, NJ. State of incorporation: NJ. Fiscal year ends September 30. SEC CIK 10795.
BDX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William M Brown | Director | Jan 29, 2026 |
| Carrie L Byington | Director | Aug 6, 2026 |
| R Andrew Eckert | Director | Jan 29, 2026 |
| Gregory Hayes | Director | Jan 29, 2026 |
| Jeffrey William Henderson | Director | Jan 29, 2026 |
| Robert Luther Huffines | Director | Aug 6, 2026 |
| Christopher Ian Montague Jones | Director | Feb 5, 2026 |
| Thomas E Jr Polen | Chairman, CEO and President | Aug 14, 2026 |
| Timothy M Ring | Director | Jan 29, 2026 |
| Bertram L Scott | Director | Feb 18, 2026 |
| Joanne Waldstreicher | Director | Jan 29, 2026 |
| Jacqueline Wright | Director | Jan 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Richard Byrd | EVP & President Interventional | Dec 1, 2025 |
| Christopher Delorefice | EVP & Chief Financial Officer | Dec 1, 2025 |
| Michael Feld | EVP, Chief Revenue Officer | Sep 29, 2026 |
| Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Jun 25, 2026 |
| Roland Goette | EVP and President, EMEA | Aug 12, 2026 |
| Peter Menziuso | EVP and President, BDI | Jun 2, 2026 |
| Lanesha Minnix | EVP and General Counsel | Mar 17, 2026 |
| Pavan Kumar Mocherla | EVP & President, Greater Asia | Dec 1, 2025 |
| Bilal Muhsin | EVP & President Connected Care | Jul 6, 2026 |
| Shana Carol Neal | EVP and Chief People Officer | Apr 6, 2026 |
| Thomas E Jr Polen | Chairman, CEO and President | Aug 14, 2026 |
| Vitor Roque | EVP & Chief Financial Officer | Sep 3, 2026 |
| David Shan | EVP and Chief ISC Officer | Jan 6, 2026 |
| Manish Sinha | EVP and Chief People Officer | Jun 22, 2026 |
| Pamela L. Spikner | SVP Controller & CAO | Mar 4, 2026 |
| Massimiliano Urbini | EVP & Chief ISC Officer | Feb 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Michael Feld | Sale | 76 | $183.70 |
| Aug 26, 2026 | Michael Feld | Sale | 165 | $188.49 |
| Aug 13, 2026 | Thomas E Jr Polen | Sale | 4,152 | $185.00 |
| Aug 11, 2026 | Roland Goette | Sale | 2,438 | $180.84 |
| Jul 27, 2026 | Michael Feld | Sale | 75 | $157.13 |
| Jun 26, 2026 | Michael Feld | Sale | 75 | $152.80 |
| Jun 24, 2026 | Michael David Garrison | Sale | 1,100 | $145.66 |
| Jun 10, 2026 | Michael David Garrison | Sale | 1,100 | $151.48 |
| Jun 1, 2026 | Thomas E Jr Polen | Sale | 2,764 | $146.35 |
| May 26, 2026 | Michael Feld | Sale | 75 | $147.35 |
| Apr 27, 2026 | Michael Feld | Sale | 74 | $151.94 |
| Mar 26, 2026 | Michael Feld | Sale | 75 | $156.83 |
| Feb 26, 2026 | Michael Feld | Sale | 75 | $181.84 |
| Feb 18, 2026 | Bertram L Scott | Sale | 953 | $182.61 |
| Jan 26, 2026 | Michael Feld | Sale | 75 | $202.73 |
BDX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | $21.84B | $1.68B | 5.82 | — |
| Sep 30, 2024 | $20.18B | $1.71B | 5.86 | — |
| Sep 30, 2023 | $19.37B | $1.48B | 4.94 | — |
| Sep 30, 2022 | $18.87B | $1.78B | 5.88 | — |
| Sep 30, 2021 | $19.13B | $2.09B | 6.85 | $4.65B |
Latest balance sheet: total assets $50.73B, total liabilities $—, cash $708.00M (as of Jun 30, 2026).
BDX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $177.07 |
| May 7, 2026 | 8-K Item 2.02 (results) | $153.26 |
| Apr 2, 2026 | 8-K Item 2.02 (results) | $154.51 |
| Feb 9, 2026 | 8-K Item 2.02 (results) | $163.04 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $139.46 |
| Oct 15, 2025 | 8-K Item 2.02 (results) | $146.83 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $147.55 |
| May 1, 2025 | 8-K Item 2.02 (results) | $133.29 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $192.66 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $178.55 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BDX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.